Compare · PETQ vs SNYR
PETQ vs SNYR
Side-by-side comparison of PetIQ Inc. (PETQ) and Synergy CHC Corp. (SNYR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PETQ and SNYR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- PETQ is the larger of the two at $570.2M, about 194.5x SNYR ($2.9M).
- SNYR has hit the wire 2 times in the past 4 weeks while PETQ has been quiet.
- PETQ has more recent analyst coverage (8 ratings vs 2 for SNYR).
- Company
- PetIQ Inc.
- Synergy CHC Corp.
- Price
- $30.99+0.02%
- $0.20-5.62%
- Market cap
- $570.2M
- $2.9M
- 1M return
- -
- -49.59%
- 1Y return
- -
- -90.75%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2024
- News (4w)
- 0
- 2
- Recent ratings
- 8
- 2
PetIQ Inc.
PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Latest PETQ
- PetIQ Names Camillo Pane as Chief Executive Officer
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- SEC Form 15-12G filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Chief Financial Officer Glasman Zvi returned 25,800 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Huff Scott returned 6,077 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP Manufacturing & Sup. Chain Lyon Chad D. returned 10,659 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, GENERAL COUNSEL Carter William J. returned 3,497 shares to the company, closing all direct ownership in the company (SEC Form 4)
Latest SNYR
- SEC Form EFFECT filed by Synergy CHC Corp.
- Synergy CHC Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form S-1 filed by Synergy CHC Corp.
- Synergy CHC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Synergy CHC Corp.
- Synergy CHC Corp. Reports First Quarter 2026 Financial Results
- Synergy CHC Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Synergy CHC Corp.
- SEC Form DEFA14A filed by Synergy CHC Corp.
- Director Kaushal Nitin was granted 306,433 shares (SEC Form 4)